Indeed, sorbitol treatment leads to a higher proportion of M1 macrophages in the colon, worsening colitis, which is reversed in interleukin-1β (IL-1β)-deficient mice and mitigated with antibiotic treatment. This evidence concerns the gene IL1B and colitis.